Description

MabThera 500mg Injection (Rituximab) – Uses, Side Effects, Dosage & Price in Pakistan

MabThera 500mg Injection (Rituximab) is a prescription biological medicine used for the treatment of certain blood cancers and autoimmune diseases. Each 50 mL vial contains 500 mg of rituximab at a concentration of 10 mg/mL. The intravenous formulation is supplied as a concentrate for solution for infusion and must be appropriately prepared and administered by trained healthcare professionals.

Rituximab is a monoclonal antibody that targets CD20, a protein found on certain B lymphocytes (B cells). By targeting CD20-positive B cells, MabThera can help control diseases in which these cells play an important role.

MabThera is a specialist medicine and should not be self-administered. Treatment must take place under medical supervision in a setting equipped to manage potentially serious infusion reactions.

Patients looking for MabThera 500mg Injection in Pakistan should purchase it only against an appropriate prescription and from a reliable source. Impo Medic provides medicine-related product and availability information for customers in Pakistan.

MabThera 500mg Injection (Rituximab) Uses

MabThera has both oncology and autoimmune-disease applications. The exact approved indications can vary between countries, so a specialist should determine whether rituximab is appropriate for an individual patient.

Non-Hodgkin’s Lymphoma

Rituximab is widely used in the management of certain CD20-positive B-cell non-Hodgkin’s lymphomas.

Depending on the type and stage of lymphoma, MabThera may be administered alone or in combination with chemotherapy. Examples include certain cases of follicular lymphoma and diffuse large B-cell lymphoma (DLBCL).

Chronic Lymphocytic Leukemia

MabThera may also be used in combination with chemotherapy for certain patients with CD20-positive chronic lymphocytic leukemia (CLL).

Treatment selection depends on several factors, including previous treatment, disease characteristics and the patient’s overall medical condition.

Rheumatoid Arthritis

Rituximab is also used for certain adults with severe active rheumatoid arthritis. In this setting, it may be given with methotrexate when previous treatment, including appropriate TNF-inhibitor therapy, has not provided an adequate response or has not been tolerated.

Granulomatosis with Polyangiitis and Microscopic Polyangiitis

MabThera can be used for certain patients with granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA). These are forms of vasculitis in which blood vessels become inflamed.

Rituximab may be administered together with glucocorticoids in appropriate patients.

Other Approved Uses

In some jurisdictions, rituximab is also approved for conditions such as pemphigus vulgaris. Approved indications differ between regions, so patients should follow the treatment indication given by their specialist rather than using general online information to determine suitability.

How Does MabThera 500mg Injection Work?

MabThera 500mg Injection (Rituximab) is a monoclonal antibody designed to recognize the CD20 antigen found on the surface of B cells.

Once rituximab binds to CD20, immune mechanisms help remove targeted B cells. This activity explains why rituximab can be useful in certain B-cell cancers as well as some autoimmune disorders in which B cells contribute to abnormal immune activity.

MabThera is therefore different from conventional chemotherapy, although it may be administered as part of a treatment plan that also contains chemotherapy.

MabThera 500mg Dosage and Administration

There is no single standard dose of MabThera suitable for every patient.

The dose and treatment schedule depend on the disease being treated, body surface area in some regimens, other medicines being given, previous treatment and the patient’s clinical condition.

For this reason, MabThera dosing must be calculated and prescribed by an oncology, hematology, rheumatology or other appropriately qualified specialist.

The 500 mg/50 mL IV vial is not administered as a rapid IV injection or bolus. It is a concentrate that must be diluted and administered as an intravenous infusion according to the appropriate protocol.

Patients may receive medicines before an infusion to reduce the risk or severity of infusion-related reactions. The treating team will also determine the appropriate infusion rate and monitoring requirements.

Never attempt to prepare, dilute or administer MabThera at home.

Side Effects of MabThera 500mg Injection

Like all medicines, MabThera 500mg Injection can cause side effects. The type and frequency of adverse effects can depend on the disease being treated and other medicines administered at the same time.

Possible adverse effects include:

• Fever
• Chills
• Headache
• Nausea
• Weakness or tiredness
• Rash or itching
• Reduced blood-cell counts
• Increased susceptibility to infections
• Infusion-related reactions

Some patients may experience reactions during or shortly after the infusion, particularly with the first administration.

Infusion-Related Reactions

Infusion-related reactions are an important safety concern with intravenous rituximab.

Symptoms can include fever, chills, rash, itching, breathing difficulty, low blood pressure or other hypersensitivity-like symptoms. Serious and, rarely, fatal infusion reactions have been reported.

For this reason, MabThera must be administered under close medical supervision with appropriate emergency treatment facilities available.

If symptoms occur during the infusion, healthcare professionals may interrupt or slow the infusion and provide appropriate treatment.

Serious Warnings and Precautions

Before receiving MabThera 500mg Injection (Rituximab), patients should provide their doctor with a complete medical history.

Infections

Rituximab affects B cells and can reduce part of the body’s immune response. Serious infections can therefore occur during or following treatment.

Tell your doctor if you currently have an infection or frequently experience infections.

Hepatitis B

Rituximab treatment can be associated with hepatitis B virus reactivation in people with current or previous HBV infection.

Patients may require hepatitis B screening before treatment. Those with evidence of previous infection may require specialist assessment and monitoring.

Progressive Multifocal Leukoencephalopathy

A rare but very serious brain infection called progressive multifocal leukoencephalopathy (PML) has been reported with rituximab.

New or worsening neurological symptoms—such as unusual weakness, changes in vision, confusion, difficulty walking or significant changes in thinking—require urgent medical assessment.

Heart Problems

Tell your doctor if you have a history of heart disease, abnormal heart rhythm, chest pain or other cardiovascular problems. Appropriate monitoring may be necessary during treatment.

Vaccination

Patients should discuss vaccinations with their healthcare team before receiving rituximab. Because MabThera alters B-cell activity, it can affect immune responses to some vaccines, and certain vaccines may not be appropriate during particular periods of treatment.

Drug Interactions

Before starting MabThera, provide your healthcare team with a complete list of prescription medicines, over-the-counter medicines, supplements and other treatments you use.

This is particularly important for medicines that affect the immune system and for other anticancer therapies.

Patients should also tell their doctor about previous biologic medicines and any planned vaccination.

Do not start or stop another medicine during rituximab treatment without consulting the healthcare team responsible for your care.

Pregnancy and Breastfeeding

Patients who are pregnant, could become pregnant, plan pregnancy or are breastfeeding should discuss this with their specialist before receiving MabThera.

Because rituximab affects B cells and can cross the placenta, pregnancy requires individual assessment. Appropriate contraception may also be recommended during treatment and for a specified period afterward.

Patients should follow the current product information and their specialist’s instructions regarding pregnancy, contraception and breastfeeding.

Storage of MabThera 500mg Injection

MabThera is a biological medicine, so appropriate storage is essential.

The unopened vial is generally stored refrigerated at 2°C to 8°C, protected from light and according to the conditions specified on the original packaging.

It should not be frozen.

Healthcare professionals should follow the manufacturer’s instructions for storage, dilution and handling. Patients purchasing the medicine should also pay particular attention to maintaining the required cold chain during transportation.

Do not use a vial that has expired, has been improperly stored or has packaging that appears damaged.

MabThera 500mg Injection Price in Pakistan

The MabThera 500mg Injection price in Pakistan can vary according to availability, supplier, import conditions and other market factors.

Because it is a specialist biological medicine requiring appropriate storage and cold-chain handling, patients should not select a supplier solely on the basis of the lowest advertised price.

For current MabThera 500mg price in Pakistan, customers can check availability through Impo Medic. Always confirm the current product price and stock status before placing an order because medicine prices and availability can change.

How to Buy MabThera 500mg Injection in Pakistan

Patients searching for MabThera 500mg Injection (Rituximab) in Pakistan should obtain it only on the recommendation and prescription of an appropriate specialist.

For high-value biological medicines, authenticity, batch details, expiry date, packaging and temperature-controlled storage are particularly important.

Customers can contact Impo Medic to check MabThera 500mg availability and purchasing information in Pakistan. The medicine should be transported and stored according to the manufacturer’s cold-chain requirements.

Buying the medicine does not replace specialist treatment. MabThera must ultimately be prepared and administered by trained healthcare professionals in an appropriate medical facility.

Why Choose Impo Medic?

Impo Medic aims to provide patients and caregivers in Pakistan with clear medicine-related product information and access to availability details for specialist medicines.

For products such as MabThera 500mg Injection, particular attention should be paid to correct strength, original packaging, expiry information and cold-chain requirements.

Patients should always verify their prescription and consult their treating specialist before purchasing or receiving rituximab.

FAQs About MabThera 500mg Injection (Rituximab)

What is MabThera 500mg Injection used for?

MabThera contains rituximab and is used for certain CD20-positive blood cancers and selected autoimmune diseases. Depending on local approvals and the patient’s condition, these can include non-Hodgkin’s lymphoma, CLL, rheumatoid arthritis and certain forms of vasculitis.

What does MabThera 500mg contain?

A 50 mL vial contains 500 mg of rituximab, corresponding to a concentration of 10 mg/mL.

Is MabThera chemotherapy?

MabThera is a monoclonal antibody therapy, not conventional cytotoxic chemotherapy. However, it is frequently used together with chemotherapy in the treatment of certain blood cancers.

How is MabThera 500mg administered?

The 500 mg IV formulation is a concentrate that is diluted and given as an intravenous infusion. It should be administered only by trained healthcare professionals under appropriate medical supervision.

Can MabThera cause an infusion reaction?

Yes. Infusion-related reactions are a recognized risk, particularly during the first infusion. Patients are monitored closely, and premedication may be given according to the treatment protocol.

Does MabThera weaken the immune system?

Rituximab reduces CD20-positive B cells and can affect immune function. This can increase susceptibility to certain infections, which is one reason medical monitoring is important.

Does MabThera need refrigeration?

Yes. The unopened IV product generally requires refrigerated storage at 2°C–8°C and protection from light. Follow the storage information on the original pack and manufacturer instructions.

Where can I check MabThera 500mg price in Pakistan?

Patients can check current MabThera 500mg Injection price and availability in Pakistan through Impo Medic. Because stock and market conditions can change, confirm the latest information when purchasing.